Monopar Therapeutics
MNPR • NASDAQ • Stock Fundamentals
Monopar Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chandler D. Robinson, with a market cap of $419.5M.
Market Cap$419.5M
Employees12.0
CEOChandler D. Robinson
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Monopar Therapeutics FAQ
Common questions about Monopar Therapeutics
Monopar Therapeutics (MNPR) has a market capitalization of $419.5M and trades on NASDAQ.
Monopar Therapeutics has approximately 12 employees.